These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20679436)

  • 1. The EspF effector, a bacterial pathogen's Swiss army knife.
    Holmes A; Mühlen S; Roe AJ; Dean P
    Infect Immun; 2010 Nov; 78(11):4445-53. PubMed ID: 20679436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction.
    Dean P; Scott JA; Knox AA; Quitard S; Watkins NJ; Kenny B
    PLoS Pathog; 2010 Jun; 6(6):e1000961. PubMed ID: 20585567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7.
    Zhao S; Zhou Y; Wang C; Yang Y; Wu X; Wei Y; Zhu L; Zhao W; Zhang Q; Wan C
    PLoS One; 2013; 8(1):e55164. PubMed ID: 23372831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
    Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
    Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
    Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
    Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of Ibe, a novel type III effector protein of A/E pathogens targeting human IQGAP1.
    Buss C; Müller D; Rüter C; Heusipp G; Schmidt MA
    Cell Microbiol; 2009 Apr; 11(4):661-77. PubMed ID: 19134119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.
    Roxas JL; Ryan K; Vedantam G; Viswanathan VK
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G374-80. PubMed ID: 24904077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF.
    Nagai T; Abe A; Sasakawa C
    J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells.
    Tahoun A; Siszler G; Spears K; McAteer S; Tree J; Paxton E; Gillespie TL; Martinez-Argudo I; Jepson MA; Shaw DJ; Koegl M; Haas J; Gally DL; Mahajan A
    Infect Immun; 2011 Nov; 79(11):4716-29. PubMed ID: 21875965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.
    Wong AR; Pearson JS; Bright MD; Munera D; Robinson KS; Lee SF; Frankel G; Hartland EL
    Mol Microbiol; 2011 Jun; 80(6):1420-38. PubMed ID: 21488979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive N-WASP-binding elements of the enterohemorrhagic Escherichia coli effector EspF(U) synergistically activate actin assembly.
    Campellone KG; Cheng HC; Robbins D; Siripala AD; McGhie EJ; Hayward RD; Welch MD; Rosen MK; Koronakis V; Leong JM
    PLoS Pathog; 2008 Oct; 4(10):e1000191. PubMed ID: 18974829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
    Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins.
    Maddocks OD; Scanlon KM; Donnenberg MS
    mBio; 2013 Jun; 4(3):e00152-13. PubMed ID: 23781066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli.
    Munera D; Martinez E; Varyukhina S; Mahajan A; Ayala-Sanmartin J; Frankel G
    Biochem J; 2012 Aug; 445(3):383-92. PubMed ID: 22587461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting.
    Quitard S; Dean P; Maresca M; Kenny B
    Cell Microbiol; 2006 Jun; 8(6):972-81. PubMed ID: 16681838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
    Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
    Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.